DOCSLIB.ORG

Cancer and the Knockout Mouse Sary for Tumorigenesis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cancer and the Knockout Mouse Sary for Tumorigenesis news and views SMADs are feedback regulators of TGF-b 2. Imamura, T. et al. Nature 389, 622–626 (1997). capacity in culture, or any reduction in the 3. Tsuneizumi, K. et al. Nature 389, 627–631 (1997). signalling opens up the question of how the 4. Nakao, A. et al. Nature 389, 631–635 (1997). ability to generate tumours when oncogene- expression and regulation of these molecules 5. Hayashi, H. et al. Cell 89, 1165–1174 (1997). transformed cells are injected into nude participates in the patterning of TGF-b 6. Topper, J. N. et al. Proc. Natl Acad. Sci. USA 94, 9314–9319 (immunodeficient) mice. responses in developing tissues. (1997). It has been suggested that progressive 7. Alevizopoulos, A. & Mermod, N. Bioessays 19, 581–591 (1997). Malcolm Whitman is in the Department of Cell 8. Neumann, C. & Cohen, S. Bioessays 19, 721–729 (1997). erosion of telomeres in somatic cells (which Biology, Harvard Medical School, 240 Longwood 9. Chen, X. et al. Nature 389, 85–89 (1997). have physiologically repressed telomerase) Avenue, Boston, Massachusetts 02115, USA. 10.Kim, J., Johnson, K., Chen, H. J., Carroll, S. & Laughon, A. represents a barrier to indefinite cell prolifer- Nature 388, 304–308 (1997). e-mail: [email protected] 11.Raftery, L. A., Twombly, V., Wharton, K. & Gelbart, W. Genetics ation. Tumour cells are thought to overcome 1. Massagué, J., Hata, A. & Liu, F. Trends Cell Biol. 7, 187–192 (1997). 139, 241–254 (1995). this block by reactivating telomerase. But the apparently undiminished tumorigenic abili- Telomerase ty of oncogene-transformed mTR –/– cells suggests that telomerase may not be neces- Cancer and the knockout mouse sary for tumorigenesis. Data showing that, in mice, telomerase can be up-regulated at David Wynford-Thomas and David Kipling an early stage in tumour development5 — before any significant telomere erosion has elomeres are specialized structures at any acute toxicity. But telomere shortening is occurred — leads the authors to hint that the the ends of linear chromosomes. They occurring: by the latest generation studied current dogma may be wrong. In other Tusually consist of tandem arrays of (G6), there is clear evidence of telomere words, telomerase may be nothing more a short DNA sequence (TTAGGG in ver- erosion, with around five per cent of chro- than a passive bystander, rather than facili- tebrates) and associated proteins, and they mosomes in embryonic fibroblasts lacking tating tumour growth4. If so, this would have are thought to have at least two essential detectable TTAGGG, accompanied by considerable implications for telomerase as a functions1. First, they stop natural chromo- increasingly frequent chromosome fusions. target for cancer therapy (although it does some ends behaving as random breaks, This ‘delay’ in manifestation of the phe- not necessarily detract from its value as a which might otherwise generate inter- notype almost certainly reflects the unusual- diagnostic marker). chromosomal fusions and activate DNA- ly long telomere-repeat arrays in the germ There are, however, good reasons for damage-induced cell-cycle arrest. Second, line of this mouse species. These repeats are exercising caution when extrapolating from they provide the structural basis for solving not exhausted until many generations have the mouse model. The main limitation is the end-replication problem2 — the inability elapsed — a human ‘knockout’ would be that the phenotype is probably not yet com- of DNA polymerases to completely replicate predicted to show a much more rapid onset. pletely developed. Although telomere fail- the end of a DNA duplex (see box). Yet, despite reaching what seems to be a criti- ure is occurring at G6, most of the chromo- In the germ line, telomeres are main- cal state of erosion, cells from generation G6 somes retain detectable TTAGGG. The very tained by the compensatory addition of do not show an obvious reduction in growth fact that viable G6 animals exist suggests TTAGGG repeats to chromosome ends. These repeats are synthesized by an enzyme The end-replication problem called telomerase (Fig. 1, overleaf), and a lack of telomerase activity — such as occurs physiologically in most adult human somat- For lagging-strand DNA a b 3’ 3’ ic cells — leads to progressive telomere replication, short RNA 5’ 5’ shortening with every cell cycle3. If such cells primers (blue) are made are forced to grow for long enough, they by RNA primase. These eventually lose telomere function leading to are then extended by 5’ 5’ 3’ 3’ end-to-end chromosome fusions and cell DNA polymerase to form death. What, then, might be the effect of Okazaki fragments. a constitutional (germline) deficiency of When these RNA 5’ 5’ telomerase? An intriguing (although still primers are removed, 3’ 3’ partial) answer is provided in the latest issue there is no way to of Cell, where Blasco et al.4 report their synthesize lagging- Primer gap Primer gap studies of a telomerase-deficient mouse. strand sequence that is 3’ extension (b). mechanism to ensure Telomerase contains an essential RNA complementary to the Why are such natural that natural chromosome component that provides the template for small region at the end blunt ends not ends are even more the specific synthesis of TTAGGG repeats. of the chromosome recognized as DNA different. This involves a Blasco et al. used transgenic technology to (which is at least as damage? One possibility degradative pathway create a germline deletion of the mTR gene, large as an RNA is that this is because which, even in which encodes the RNA component of primer). So, with unnatural ends have a telomerase-deficient mouse telomerase. The authors bred continuing cell division, slightly different human cells, results in 3’ homozygous, null mTR–/– mice which sequence is lost from chemical structure; for extensions for most turned out to be both viable and fertile, the ends of linear example, radiation- chromosome ends9. despite having no detectable telomerase chromosomes. Some induced blunt ends can This may be analogous activity. Moreover, the mice have now been blunt-ended daughter have terminal 3’ to a degradative maintained for six generations (G1–6). The molecules are produced phosphoglycolate pathway that has absence of any initial phenotype is striking. by this scheme, residues whereas been described in So is the fact that the next few generations irrespective of whether physiological ends do budding yeast, involving have also shown no symptoms, suggesting the starting terminus is not. Human cells may Cdc13p and other that the telomerase inhibitors that have been blunt-ended (a) or has a have an additional proteins10. D.W.-T. & D.K. envisaged for cancer therapy will not have NATURE | VOL 389 | 9 OCTOBER 1997 Nature © Macmillan Publishers Ltd 1997 551 news and views Figure 1 Synthesis of telomeric DNA Daedalus a by telomerase. a, A short region of * * 3’ the upper strand of the telomere Smooth ascent (composed of TTAGGG repeats) 5’ cannot be copied by normal DNA A solid-fuel rocket is simply an enormous Telomerase replication (see box) and is indicated firework. Once lit, it cannot be stopped or by asterisks. b, Telomerase controlled. Furthermore, it burns in b circumvents this by synthesizing new massively turbulent flow, generating 3’ TTAGGG repeats (blue), allowing the extreme vibration. Everything that has to ends to be copied by conventional fly in a rocket must pass a searching 5’ DNA replication (c). Mouse vibration test. Daedalus is now devising a DNA polymerase telomerase carries an RNA molecule less vibrant way to climb into space. that acts as a template for synthesis of A typical solid fuel is a mixture of 4 c the TTAGGG sequence. Blasco et al. aluminium powder and ammonium * * 3’ have deleted the mTR gene (which perchlorate, formed into a resilient solid encodes this RNA molecule) in the by a polymeric binder. DREADCO 5’ mouse germ line.The resultant chemists are replacing the aluminium knockout mice have no telomerase powder by fine aluminium wire, and the Primer gap activity, and their telomeres become binder by a water-based gel. The product is shorter with continuing cell division. just damp enough so that ignition cannot spread through it spontaneously; but each that interference with chromosome func- cell death), and natural chromosome ends element can be ignited by passing a current tion may need to be more widespread to (which do not). It has been assumed that in through the local aluminium wire. The compromise cell proliferation severely. It mammalian cells, specific terminal DNA charge will be fired controllably, element seems improbable that the observed telo- sequences and associated proteins somehow by element, by passing a programmed mere erosion could continue unabated ‘shield’ the natural end of the chromosome sequence of current pulses through the without eventually stopping growth. For and prevent it from activating genome- wires. example, viral-oncogene-transformed hu- damage-monitoring systems. The later- In this simple form, the idea is clearly man cells eventually undergo ‘crisis’ (cell generation mTR –/– cells show an apparent impractical. A big rocket motor could have death) during continuous culture, unless loss of telomere-protective function (as millions of ignitable elements, far too telomere erosion is halted by activation of judged by end-to-end fusions in metaphase many for each to have its own electrical either telomerase3 or of an alternative path- chromosome preparations). But the fact leads. But Daedalus recalls the old flashbar way6. A remarkable counterpart in vivo may that such cells have reached metaphase units for small cameras, which carried ten be the spontaneous tumour regression that suggests that they have passed through at separate flash-bulbs. As each bulb fired, it occurs in a subset of childhood neuroblast- least one damage-sensing checkpoint (at carbonized and caused a lead to the next omas (so-called stage IV-S), which appar- G2–M), despite having critically eroded bulb to become conducting.
Load more

Recommended publications
  • What Are Knockout Mice?
    Lecture 37 Knockout mice Lecture 29 Cloning and Expression vectors Lecture 30 Eukaryotic Protein Expression Systems –I Lecture 31 Eukaryotic Protein Expression Systems –II Lecture 32 Eukaryotic Protein Expression Systems –III Lecture 33 Human Gene Therapy Lecture 34 DNA Vaccines Lecture 35 Transgenic Animals Lecture 36 Transgenic Plants Lecture 37 Knockout Mice What are knockout mice? A knockout mouse is a mouse in which a specific gene has been inactivated or “knocked out” by replacing it or disrupting it with an artificial piece of DNA. The loss of gene activity often causes changes in a mouse's phenotype and thus provides valuable information on the function of the gene. Researchers who developed the technology for the creation of knockout mice won Nobel Prize in the year 2007 The Nobel Prize in Physiology or Medicine 2007 was awarded jointly to Mario R. Capecchi, Sir Martin J. Evans and Oliver Smithies "for their discoveries of principles for introducing specific gene modifications in mice by the use of embryonic stem cells". Mario R. Capecchi Sir Martin J. Evans Oliver Smithies The ability to delete or mutate any gene of interest in mice has transformed the landscape of mammalian biology research. Cultivation of embryonic stem (ES) cells – Martin Evans • Gene targeting – Oliver Smithies • Gene knockout – Mario Capecchi Gene correction by Oliver Smithies Targeted correction of a mutant HPRT gene in mouse ES cells. Nature 330:576-8, 1987 This modification of a chosen gene in pluripotent ES cells demonstrates the feasibility of this route to manipulating mammalian genomes in predetermined ways. -------------------------------------------------------------------------------------- Nature. 1985 Sep 19-25;317(6034):230-4.
    [Show full text]
  • The Human Genome Project Focus of the Human Genome Project
    TOOLS OF GENETIC RESEARCH THE HUMAN GENOME PROJECT FOCUS OF THE HUMAN GENOME PROJECT The primary work of the Human Genome Project has been to Francis S. Collins, M.D., Ph.D.; produce three main research tools that will allow investigators to and Leslie Fink identify genes involved in normal biology as well as in both rare and common diseases. These tools are known as positional cloning The Human Genome Project is an ambitious research effort aimed at deciphering the chemical makeup of the entire human (Collins 1992). These advanced techniques enable researchers to ge ne tic cod e (i.e. , the g enome). The primary wor k of the search for disease­linked genes directly in the genome without first having to identify the gene’s protein product or function. (See p ro j e c t i s t o d ev e lop t h r e e r e s e a r c h tool s t h a t w i ll a ll o w the article by Goate, pp. 217–220.) Since 1986, when researchers scientists to identify genes involved in both rare and common 2 diseases. Another project priority is to examine the ethical, first found the gene for chronic granulomatous disease through legal, and social implications of new genetic technologies and positional cloning, this technique has led to the isolation of consid­ to educate the public about these issues. Although it has been erably more than 40 disease­linked genes and will allow the identi­ in existence for less than 6 years, the Human Genome Project fication of many more genes in the future (table 1).
    [Show full text]
  • Generation of Mouse Conditional Knockout Alleles in One Step Using the I-GONAD Method
    Downloaded from genome.cshlp.org on September 29, 2021 - Published by Cold Spring Harbor Laboratory Press Method Generation of mouse conditional knockout alleles in one step using the i-GONAD method Renjie Shang,1,2 Haifeng Zhang,1 and Pengpeng Bi1,2 1Center for Molecular Medicine, University of Georgia, Athens, Georgia 30602, USA; 2Department of Genetics, University of Georgia, Athens, Georgia 30602, USA The Cre/loxP system is a powerful tool for gene function study in vivo. Regulated expression of Cre recombinase mediates precise deletion of genetic elements in a spatially– and temporally–controlled manner. Despite the robustness of this system, it requires a great amount of effort to create a conditional knockout model for each individual gene of interest where two loxP sites must be simultaneously inserted in cis. The current undertaking involves labor-intensive embryonic stem (ES) cell– based gene targeting and tedious micromanipulations of mouse embryos. The complexity of this workflow poses formida- ble technical challenges, thus limiting wider applications of conditional genetics. Here, we report an alternative approach to generate mouse loxP alleles by integrating a unique design of CRISPR donor with the new oviduct electroporation technique i-GONAD. Showing the potential and simplicity of this method, we created floxed alleles for five genes in one attempt with relatively low costs and a minimal equipment setup. In addition to the conditional alleles, constitutive knockout alleles were also obtained as byproducts of these experiments. Therefore, the wider applications of i-GONAD may promote gene func- tion studies using novel murine models. [Supplemental material is available for this article.] Our understanding of the genetic mechanisms of human diseases strains are readily available, generation of the loxP-flanked (floxed) has been largely expanded by loss-of-function studies using engi- alleles is challenging and labor-intensive due to the lack of an effi- neered mouse models.
    [Show full text]
  • Generation of Knockout Mouse Models of Cyclin-Dependent Kinase Inhibitors by Engineered Nuclease-Mediated Genome Editing
    ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Lab Anim Res 2018: 34(4), 264-269 https://doi.org/10.5625/lar.2018.34.4.264 Generation of knockout mouse models of cyclin-dependent kinase inhibitors by engineered nuclease-mediated genome editing Bo Min Park, Jae-il Roh*, Jaehoon Lee*, Han-Woong Lee* Department of Biochemistry, College of Life Science & Biotechnology, Yonsei University, Seoul, Korea Cell cycle dysfunction can cause severe diseases, including neurodegenerative disease and cancer. Mutations in cyclin-dependent kinase inhibitors controlling the G1 phase of the cell cycle are prevalent in various cancers. Mice lacking the tumor suppressors p16Ink4a (Cdkn2a, cyclin-dependent kinase inhibitor 2a), p19Arf (an alternative reading frame product of Cdkn2a,), and p27Kip1 (Cdkn1b, cyclin-dependent kinase inhibitor 1b) result in malignant progression of epithelial cancers, sarcomas, and melanomas, respectively. Here, we generated knockout mouse models for each of these three cyclin-dependent kinase inhibitors using engineered nucleases. The p16Ink4a and p19Arf knockout mice were generated via transcription activator-like effector nucleases (TALENs), and p27Kip1 knockout mice via clustered regularly interspaced short palindromic repeats/CRISPR-associated nuclease 9 (CRISPR/Cas9). These gene editing technologies were targeted to the first exon of each gene, to induce frameshifts producing premature termination codons. Unlike preexisting embryonic stem cell-based knockout mice, our mouse models are free from selectable markers or other external gene insertions, permitting more precise study of cell cycle-related diseases without confounding influences of foreign DNA. Keywords: TALEN, CRISPR/Cas9, cyclin-dependent kinase inhibitor Received 20 October 2018; Revised version received 7 December 2018; Accepted 8 December 2018 The cell cycle constitutes a series of events required proteins can cause severe disease [16,25,33].
    [Show full text]
  • Generating Mouse Models for Biomedical Research: Technological Advances Channabasavaiah B
    © 2019. Published by The Company of Biologists Ltd | Disease Models & Mechanisms (2019) 12, dmm029462. doi:10.1242/dmm.029462 AT A GLANCE Generating mouse models for biomedical research: technological advances Channabasavaiah B. Gurumurthy1,2 and Kevin C. Kent Lloyd3,4,* ABSTRACT recombination in embryonic stem cells has given way to more refined Over the past decade, new methods and procedures have been methods that enable allele-specific manipulation in zygotes. We also developed to generate geneticallyengineered mouse models of human highlight advances in the use of programmable endonucleases that disease. This At a Glance article highlights several recent technical have greatly increased the feasibility and ease of editing the mouse advances in mouse genome manipulation that have transformed genome. Together, these and other technologies provide researchers our ability to manipulate and study gene expression in the mouse. with the molecular tools to functionally annotate the mouse genome We discuss how conventional gene targeting by homologous with greater fidelity and specificity, as well as to generate new mouse models using faster, simpler and less costly techniques. 1Developmental Neuroscience, Munroe Meyer Institute for Genetics and KEY WORDS: CRISPR, Genome editing, Mouse, Mutagenesis Rehabilitation, University of Nebraska Medical Center, Omaha, NE 68106-5915, USA. 2Mouse Genome Engineering Core Facility, Vice Chancellor for Research Office, University of Nebraska Medical Center, Omaha, NE 68106-5915, USA. Introduction 3Department
    [Show full text]
  • Double-Strand Break Repair Pathways in Dna Structure-Induced Genetic Instability
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 8-2010 DOUBLE-STRAND BREAK REPAIR PATHWAYS IN DNA STRUCTURE-INDUCED GENETIC INSTABILITY Diem T. Kha Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Laboratory and Basic Science Research Commons Recommended Citation Kha, Diem T., "DOUBLE-STRAND BREAK REPAIR PATHWAYS IN DNA STRUCTURE-INDUCED GENETIC INSTABILITY" (2010). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 76. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/76 This Thesis (MS) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. DOUBLE-STRAND BREAK REPAIR PATHWAYS IN DNA STRUCTURE-INDUCED GENETIC INSTABILITY BY Diem Thi Kha, Bachelor of Science APPROVED: ______________________________ Karen M. Vasquez, Ph.D., Supervisory ______________________________
    [Show full text]
  • Manipulating the Mouse Genome Using Recombineering
    e in G net ts ic n E e n Biswas and Sharan, Adv Genet Eng 2013, 2:2 g m i e n c e e n DOI: 10.4172/2169-0111.1000108 r a i v n d g A Advancements in Genetic Engineering ISSN: 2169-0111 Review Article Open Access Manipulating the Mouse Genome Using Recombineering Kajal Biswas and Shyam K Sharan* Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland 21702, USA Abstract Genetically engineered mouse models are indispensable for understanding the biological function of genes, understanding the genetic basis of human diseases, and for preclinical testing of novel therapies. Generation of such mouse models has been possible because of our ability to manipulate the mouse genome. Recombineering is a highly efficient, recombination-based method of genetic engineering that has revolutionized our ability to generate mouse models. Since recombineering technology is not dependent on the availability of restriction enzyme recognition sites, it allows us to modify the genome with great precision. It requires homology arms as short as 40 bases for recombination, which makes it relatively easy to generate targeting constructs to insert, change, or delete either a single nucleotide or a DNA fragment several kb in size; insert selectable markers or reporter genes; or add epitope tags to any gene of interest. In this review, we focus on the development of recombineering technology and its application to the generation of genetically engineered mouse models. High-throughput generation of gene targeting vectors, used to construct knockout alleles in mouse embryonic stem cells, is now feasible because of this technology.
    [Show full text]
  • Embryo-Based Large Fragment Knock-In in Mammals: Why, How and What’S Next
    G C A T T A C G G C A T genes Review Embryo-Based Large Fragment Knock-in in Mammals: Why, How and What’s Next Steven Erwood 1,2 and Bin Gu 3,* 1 Program in in Genetics and Genome Biology, Hospital for Sick Children, Toronto, ON M5G 0A4, Canada; [email protected] 2 Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada 3 Program in Developmental and Stem Cell Biology, Hospital for Sick Children, Toronto, ON M5G 0A4, Canada * Correspondence: [email protected]; Tel.: +647-702-9608; Fax: 416-813-6382 Received: 31 December 2019; Accepted: 26 January 2020; Published: 29 January 2020 Abstract: Endonuclease-mediated genome editing technologies, most notably CRISPR/Cas9, have revolutionized animal genetics by allowing for precise genome editing directly through embryo manipulations. As endonuclease-mediated model generation became commonplace, large fragment knock-in remained one of the most challenging types of genetic modification. Due to their unique value in biological and biomedical research, however, a diverse range of technological innovations have been developed to achieve efficient large fragment knock-in in mammalian animal model generation, with a particular focus on mice. Here, we first discuss some examples that illustrate the importance of large fragment knock-in animal models and then detail a subset of the recent technological advancements that have allowed for efficient large fragment knock-in. Finally, we envision the future development of even larger fragment knock-ins performed in even larger animal models, the next step in expanding the potential of large fragment knock-in in animal models.
    [Show full text]
  • Genes Adapt to Outsmart Gene Targeting Strategies in Mutant Mouse Strains by Skipping Exons to Reinitiate Transcription and Translation
    bioRxiv preprint doi: https://doi.org/10.1101/2020.04.22.041087; this version posted April 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Genes adapt to outsmart gene targeting strategies in mutant mouse strains by skipping exons to reinitiate transcription and translation Vishnu Hosur1*, Benjamin E. Low1, Daniel Li2, Grace A. Stafford1, Vivek Kohar1, Leonard D. Shultz1, Michael V. Wiles1* 1The Jackson Laboratory for Mammalian Genetics, Bar Harbor, ME. 2Arthritis and Tissue Degeneration Program, Hospital for Special Surgery at Weill Cornell Medicine, New York, NY, 10021 *Correspondence: [email protected]; [email protected] Abstract Gene disruption in mouse embryonic stem cells or zygotes is a conventional genetics approach to identify gene function in vivo. However, because different gene-disruption strategies use different mechanisms to disrupt genes, the strategies can result in diverse phenotypes in the resulting mouse model. To determine whether different gene-disruption strategies affect the phenotype of resulting mutant mice, we characterized Rhbdf1 mouse mutant strains generated by three commonly used strategies—definitive-null, targeted knockout (KO)-first, and CRISPR/Cas9. We find that Rhbdf1 responds differently to distinct KO strategies, for example, by skipping exons and reinitiating translation to potentially yield gain-of-function alleles rather than the expected null or severe hypomorphic alleles. Our analysis also revealed that at least 4% of mice generated using the KO-first strategy show conflicting phenotypes, suggesting that exon skipping is a widespread phenomenon occurring across the genome.
    [Show full text]
  • Dual AAV-Mediated Gene Therapy Restores Hearing in a DFNB9 Mouse Model
    Dual AAV-mediated gene therapy restores hearing in a DFNB9 mouse model Omar Akila, Frank Dykab, Charlotte Calvetc,d,e, Alice Emptozc,d,e, Ghizlene Lahlouc,d,e, Sylvie Nouaillec,d,e, Jacques Boutet de Monvelc,d,e, Jean-Pierre Hardelinc,d,e, William W. Hauswirthb, Paul Avanf, Christine Petitc,d,e,g,1, Saaid Safieddinec,d,e,h,1, and Lawrence R. Lustigi aDepartment of Otolaryngology–Head and Neck Surgery, University of California, San Francisco, CA; bDepartment of Ophthalmology, College of Medicine, University of Florida, Gainesville, FL 32610; cGenetics and Physiology of Hearing Laboratory, Institut Pasteur, 75015 Paris, France; dInserm Unité Mixte de Recherche en Santé 1120, Institut National de la Santé et de la Recherche Médicale, 75015 Paris, France; eComplexité du Vivant, Sorbonne Universités, F-75005 Paris, France; fLaboratoire de Biophysique Sensorielle, Faculté de Médecine, Centre Jean Perrin, Université d’Auvergne, 63000 Clermont-Ferrand, France; gCollège de France, 7505 Paris, France; hCentre National de la Recherche Scientifique, 75794 Paris, France; and iDepartment of Otolaryngology–Head and Neck Surgery, Columbia University Medical Center and New York Presbyterian Hospital, New York, NY 10032 Contributed by Christine Petit, November 27, 2018 (sent for review October 12, 2018; reviewed by Jonathan Gale and Botond Roska) Autosomal recessive genetic forms (DFNB) account for most cases of (about 4.7 kb) makes it difficult to use this technique for larger profound congenital deafness. Adeno-associated virus (AAV)-based genes, such as Otof (cDNA ∼6kb).Weovercamethissize gene therapy is a promising therapeutic option, but is limited by a limitation by adapting a previously reported dual AAV-vector potentially short therapeutic window and the constrained packaging method for the delivery of large cDNAs (29).
    [Show full text]
  • KNOCKOUT MOUSE MODELS for HUMAN DISEASES Muhammad Nazir, Suruchika Gaur, Abdallah Alsaadi, Mahmoud Yasser and Mohammed Saif
    Available Online at http://www.recentscientific.com International Journal of Recent Scientific International Journal of Recent Scientific Research Research Vol. 6, Issue, 7, pp.5517-5520, July, 2015 ISSN: 0976-3031 RESEARCH ARTICLE KNOCKOUT MOUSE MODELS FOR HUMAN DISEASES Muhammad Nazir, Suruchika Gaur, Abdallah Alsaadi, Mahmoud Yasser and Mohammed Saif ARTICLEDepartment INFO of Zoology,ABSTRACT Dyal Singh College, University of Delhi, Lodhi Road, New Delhi, 110003 Article History: Knockout mouse models are the mice used as a model to study human diseases by knowing the function Received 14th, June, 2015 of genes causing disease or study the function of unknown genes It can be done using transgenic mice Received in revised form 23th, with introducing a foreign gene or deleting an existing gene in them. Knocking out a gene that is June, 2015 corresponding to disease will cause the disease in mice. Knockout mice resemble the human disease in Accepted 13th, July, 2015 similar gene which is used to find new drug targets and try different treatments on mice to see the effect. Published online 28th, To introduce a knockout gene in mice, either homologous recombination or Cre-lox system must be used. July, 2015 Knockout mice are produced to study and compare different dysfunction genes with human diseases to come up with a treatment for different cases. Key words: Knockout mouse, homologous recombination, knockout Copyright © Abdallah Alsaadi, et al . This is an open-access article distributed under the terms of the Creative Commons Attribution License,INTRODUCTION which permits unrestricted use, distribution and reproduction instudy any medium,the development provided the of original humans, work diseaseis properly and cited.
    [Show full text]
  • Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss
    cells Review Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss 1, 1, 1 1,2,3 1 Gayle B. Collin y, Navdeep Gogna y, Bo Chang , Nattaya Damkham , Jai Pinkney , Lillian F. Hyde 1, Lisa Stone 1 , Jürgen K. Naggert 1 , Patsy M. Nishina 1,* and Mark P. Krebs 1,* 1 The Jackson Laboratory, Bar Harbor, Maine, ME 04609, USA; [email protected] (G.B.C.); [email protected] (N.G.); [email protected] (B.C.); [email protected] (N.D.); [email protected] (J.P.); [email protected] (L.F.H.); [email protected] (L.S.); [email protected] (J.K.N.) 2 Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand 3 Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand * Correspondence: [email protected] (P.M.N.); [email protected] (M.P.K.); Tel.: +1-207-2886-383 (P.M.N.); +1-207-2886-000 (M.P.K.) These authors contributed equally to this work. y Received: 29 February 2020; Accepted: 7 April 2020; Published: 10 April 2020 Abstract: Inherited retinal degeneration (RD) leads to the impairment or loss of vision in millions of individuals worldwide, most frequently due to the loss of photoreceptor (PR) cells. Animal models, particularly the laboratory mouse, have been used to understand the pathogenic mechanisms that underlie PR cell loss and to explore therapies that may prevent, delay, or reverse RD. Here, we reviewed entries in the Mouse Genome Informatics and PubMed databases to compile a comprehensive list of monogenic mouse models in which PR cell loss is demonstrated.
    [Show full text]